Association of high serum β2-microglobulin levels with poor functional outcomes in patients with acute ischemic stroke: A cohort study

Shan Yu,Peng Yin,Xiujuan Li,Jian Xiao,Hao Zhang,Liangqi Zhou,Ying Tian
DOI: https://doi.org/10.1097/md.0000000000039525
IF: 1.6
2024-09-02
Medicine
Abstract:Stroke is the second leading cause of disability and death in humans due to the continually increasing burden of cardiovascular risk factors and an aging population worldwide. Recent estimates place the lifetime risk of stroke at 25%. [ 1 ] In China, 70% of stroke survivors are unable to live alone due to a poor prognosis. [ 2 ] An acute ischemic stroke (AIS) event is likely to result in neuronal damage and functional disability, with inflammation and immune responses possibly driving such outcomes. [ 3 , 4 ] Currently, known risk factors and blood biomarkers cannot fully explain the poor prognosis of AIS. [ 5 , 6 ] The expression levels of β2-microglobulin (β2M), a commonly used clinical blood marker, have potentially been overlooked as a contributing factor in terms of functional outcomes in patients with AIS.
medicine, general & internal
What problem does this paper attempt to address?